statistiche ricercatore

Continente	#
NA - Nord America	775
AS - Asia	746
EU - Europa	459
Continente sconosciuto - Info sul continente non disponibili	38
SA - Sud America	36
AF - Africa	26
Totale	2.080

Nazione	#
US - Stati Uniti d'America	751
CN - Cina	185
SG - Singapore	182
VN - Vietnam	157
HK - Hong Kong	127
GB - Regno Unito	111
SE - Svezia	86
DE - Germania	61
IT - Italia	41
FR - Francia	32
IN - India	26
UA - Ucraina	25
BR - Brasile	24
RU - Federazione Russa	20
IE - Irlanda	18
KR - Corea	17
NL - Olanda	17
CA - Canada	12
CI - Costa d'Avorio	11
JO - Giordania	11
JP - Giappone	11
FI - Finlandia	8
ZA - Sudafrica	8
BE - Belgio	7
CH - Svizzera	7
HR - Croazia	7
MX - Messico	7
EE - Estonia	6
AR - Argentina	5
PL - Polonia	5
TW - Taiwan	5
BD - Bangladesh	4
PH - Filippine	4
TH - Thailandia	4
ES - Italia	3
ID - Indonesia	3
AT - Austria	2
CO - Colombia	2
CR - Costa Rica	2
EC - Ecuador	2
IR - Iran	2
NG - Nigeria	2
SA - Arabia Saudita	2
TG - Togo	2
A2 - ???statistics.table.value.countryCode.A2???	1
BG - Bulgaria	1
BO - Bolivia	1
BS - Bahamas	1
CM - Camerun	1
GR - Grecia	1
HN - Honduras	1
IQ - Iraq	1
KN - Saint Kitts e Nevis	1
LK - Sri Lanka	1
MA - Marocco	1
MY - Malesia	1
OM - Oman	1
PK - Pakistan	1
PY - Paraguay	1
RO - Romania	1
SC - Seychelles	1
TR - Turchia	1
UY - Uruguay	1
Totale	2.043

Nome	#
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium	277
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.	266
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience	212
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.	211
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.	209
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.	162
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.	158
The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma	155
Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies.	154
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine	150
null	97
Gemcitabine	29
Totale	2.080

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	218	19	3	19	27	18	10	3	12	7	19	49	32
2022/2023	278	39	24	11	29	22	22	4	14	68	4	20	21
2023/2024	43	3	9	2	7	6	10	1	2	0	2	0	1
2024/2025	228	2	31	11	13	34	8	12	2	4	25	12	74
2025/2026	760	47	55	57	44	155	74	71	19	145	49	38	6
2026/2027	16	16	0	0	0	0	0	0	0	0	0	0	0
Totale													2.080

CRIS Current Research Information System